In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug ...

San Diego-based Protego Biopharma, a biotech developing small molecule therapeutics that reprogram protein folding to address ...

Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...

Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.

The company was created to use AI for world- changing science — and achieved that with AlphaFold. But the advent of large ...

U.S. President Donald Trump on Monday signed an executive order to launch a government-wide effort to build an integrated artificial intelligence platform to harness federal scientific datasets to ...

A team led by Cleveland Clinic’s Kenneth Merz, PhD, and IBM’s Antonio Mezzacapo, PhD, is developing quantum computing methods to simulate and study supramolecular processes that guide how entire ...

A new federal initiative aims to accelerate scientific discovery by uniting artificial intelligence with large federal ...

The executive order signed on Monday directs the Department of Energy’s national laboratories to create the A.I. platform in partnership with A.I. companies.

A White House official called Genesis "the largest marshaling of federal scientific resources since the Apollo program." ...

The internet giant has released new AI software and struck deals, such as a chip tie-up with Anthropic PBC, that have ...

National laboratories have been instructed to broaden access to their data sets to accelerate research as part of the federal government’s AI platform. But who stands to benefit?